detect prolifer rate breast cancer correl clinic patholog featur situ determin prolif activ breast cancer use monoclon antibodi immunohistochem method tumor prolifer rate size nodal statu relationship prolif activ nuclear estrogen receptor content adjac tissu section valu median valu premenopaus patient valu median valu postmenopaus one median valu author correl lymph nodal involv signific relationship tumor size invers correl spearman coeffici valu nuclear estrogen receptor content result similar kinet measur situ detect prolifer rate use method cell cycl inform follow-up studi eventu prognost relev 